Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Oropharyngeal aspiration of ricin as a lung challenge model for evaluation of the therapeutic index of antibodies against ricin A-chain for post-exposure treatment.

Authors: Pratt, Timothy S; Pincus, Seth H; Hale, Martha L; Moreira, Andre L; Roy, Chad J; Tchou-Wong, Kam-Meng

Published In Exp Lung Res, (2007 Oct-Nov)

Abstract: To investigate the effectiveness of passive antibody treatment as post-exposure therapy for ricin, we had developed an oropharyngeal aspiration model for ricin lethal challenge and antibody administration. When polyclonal anti-deglycosylated ricin A-chain antibody (dgA Ab) was administered between 1-18 hr after ricin challenge, all animals survived while delayed treatment to 24 hr resulted in 30% survival. The protective effects of dgA Ab correlated with inhibition of apoptosis in the lungs in vivo and in RAW264.7 macrophage and Jurkat T cells in vitro. In addition, ricin-induced cell cytotoxicity was inhibited by both dgA Ab and RAC18 monoclonal antibody against ricin A-chain. Administration of RAC18 monoclonal antibody at 4, 18, and 24 hr after ricin exposure resulted in 100%, 60% and 50% protection, respectively, suggesting that the therapeutic window for passive vaccination extended to at least 24 hr post-ricin lung challenge.

PubMed ID: 17994372 Exiting the NIEHS site

MeSH Terms: Animals; Antibodies, Monoclonal/therapeutic use; Antibodies/therapeutic use*; Apoptosis/drug effects; Cell Line; Cell Survival/drug effects; Humans; Inflammation/chemically induced; Lung/drug effects*; Male; Mice; Mice, Inbred BALB C; Oropharynx/drug effects; Pulmonary Edema/chemically induced; Ricin/analysis; Ricin/immunology; Ricin/toxicity*

to Top